Fatty Liver After Menopause: What the Glutathione Research Shows

Why does fatty liver risk rise after menopause?

Fatty liver, where fat accumulates inside liver cells, becomes noticeably more common after menopause. A 2022 study published in Nutrition Research, led by Muzsik-Kazimierska and colleagues, measured exactly why that might be happening at the cellular level, not just the statistical level.

The researchers studied 131 postmenopausal women and sorted them by a hepatic steatosis index, a liver-fat score calculated from routine blood work. Women scoring above 36 on that index, consistent with fatty liver, had measurably lower levels of glutathione, choline, and betaine in their blood than women scoring below it. All three of those compounds play a direct role in how the liver processes fat and defends itself from oxidative damage.

A few things matter about what this study can and cannot tell us.

What this study does and does not prove

• It is observational. It shows an association, not that raising these compounds reverses fatty liver in people.
• It studied postmenopausal women specifically, which is why it matters more here than a general population study would.
• It used a validated liver-fat score, the hepatic steatosis index, rather than diagnosing fatty liver by imaging alone.
• It did not test any intervention, including shilajit. It is the clearest human evidence of the pattern, not a treatment trial.

What does glutathione have to do with your liver?

Glutathione is the body's primary internal antioxidant. It is built from three amino acids, glycine, cysteine, and glutamate. The liver is both the body's biggest glutathione factory and one of its biggest consumers, using it constantly to neutralize the oxidative byproducts of ordinary metabolism and to process substances that pass through the organ.

A 2024 systematic review in the journal Antioxidants describes glutathione depletion as central to how fatty liver disease develops and progresses, not a side effect of it. As the liver's fat load rises, oxidative stress rises with it, and that oxidative stress consumes glutathione faster than the liver can replace it. The review frames this as a two-way spiral rather than a single cause and effect.

A few reasons glutathione gets singled out.

Why glutathione specifically, and not just "antioxidants" generally

• It is made primarily inside liver cells themselves, rather than absorbed intact from food, which ties it directly to that organ's own metabolic health
• Research consistently measures it as a biomarker of liver oxidative stress, which is why it shows up across so many fatty liver studies
• A separate 2019 review in Nutrients notes that glycine, one of glutathione's three building blocks, runs roughly 60% lower with a roughly 50% lower synthesis rate in people with type 2 diabetes, a condition that frequently overlaps with fatty liver

How does losing estrogen affect your liver's defenses?

The estrogen connection here is not theoretical. A 2016 study in female mice found that the ovary is directly required to maintain the liver's glutathione defenses. When researchers removed the ovaries, a key glutathione-related enzyme in the liver, glutathione peroxidase-1, dropped, and liver lipid damage rose. When the researchers exposed liver tissue to ovarian-produced signals in the lab, that same protective enzyme rose back up.

A separate 2010 study in aged, ovariectomized rats found that restoring estrogen improved the ratio of active to inactive glutathione in the body and lowered a marker of lipid damage. Both studies are animal research. Both point the same direction. Ovarian hormone production actively defends the liver's glutathione supply, not just general health in a vague sense.

Here is what that chain likely means in practice.

What this means for the menopause transition specifically

1. As estrogen production declines, one of the signals that maintains hepatic glutathione defenses declines with it
2. That decline is a plausible mechanism behind the human finding above, where postmenopausal women with fatty liver had measurably lower glutathione
3. It is consistent with population data showing fatty liver risk rising in the years after menopause, not before it
4. None of this means hormone levels alone determine liver fat. Diet, activity, and genetics all still matter heavily

What does the shilajit research on liver health actually show?

Two animal studies have tested shilajit's effect on the liver directly, and both point the same direction as the glutathione research above.

A 2020 study fed rats a high-fat diet for 12 weeks to induce fatty liver, then treated them with shilajit for two weeks. Compared to untreated rats, the shilajit-treated animals showed significantly lower liver enzymes (AST, ALT), triglycerides, total cholesterol, LDL cholesterol, and blood sugar, along with reduced liver weight and fat accumulation. HDL cholesterol, the protective kind, rose. The study also measured the rats' antioxidant-to-oxidant balance directly and found it restored toward normal.

A second, more recent study tested a shilajit extract against acute liver injury in mice and liver cells, using the same kind of injury acetaminophen overdose causes. The shilajit-treated group showed liver enzyme reductions of roughly 70 to 75% compared to untreated animals, and the researchers specifically measured the antioxidant enzymes SOD, MDA, CAT, and glutathione itself, finding all of them moved in the protective direction.

A few limits are worth stating plainly here.

The honest limits of this evidence

• Both studies are animal research. No human trial has tested shilajit specifically for fatty liver or liver enzymes.
• The second study used an acute liver-injury model, not a fatty liver model, so it demonstrates liver protection broadly rather than fatty liver reversal specifically.
• Neither study measured postmenopausal hormone status, since both used standard laboratory animals.
• What they do show, consistently across two separate research teams, is that shilajit measurably supports the same antioxidant system, glutathione included, that the human fatty liver research above points to.

How does the shilajit evidence compare to other approaches?

The table is not a ranking of which works best. It is a map of what kind of evidence exists for each approach, so a reasonable decision can be made from an honest picture rather than a marketing claim.

What can you actually do about it?

Short of a human shilajit trial, the clearest, most evidence-backed steps for liver health after menopause come from the broader research base, not from any single supplement:

• Maintaining or losing weight through diet and activity remains the best human-trial-supported way to reduce liver fat directly
• Adequate protein intake supports the glycine supply the liver needs to keep making its own glutathione
• Limiting added sugar and alcohol reduces two of the liver's biggest additional oxidative burdens
• A liver panel at a regular checkup, specifically AST and ALT, catches early changes before symptoms appear, since fatty liver is often silent

See Optimum Shilajit

Optimum Shilajit is sourced from the Altai mountains and standardized for fulvic acid content, the compound tied most consistently to its documented antioxidant research. See Optimum Shilajit.

See Optimum Shilajit